Concord Medical Services Holdings Limited
CCM · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $4 | $3 | $3 | $3 |
| Enterprise Value | $4 | $3 | $3 | $3 |
| Revenue | $0 | $1 | $0 | $0 |
| % Growth | -28.6% | 13.8% | -2.8% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -20.6% | -14.3% | -32.3% | -11.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -90% | -64% | -85.1% | -74.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -80.3% | -55.4% | -103.7% | -55.9% |
| EPS Diluted | -2,116.8 | -2,044.2 | -3,362.7 | -5,635.5 |
| % Growth | -3.6% | 39.2% | 40.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$1 | -$0 | -$1 | -$1 |